Contact
Please use this form to send email to PR contact of this press release:
Diverse Biotech Inc. Receives Landmark USPTO Patent Allowance for Disruptive Dual-Action Therapeutic Class
TO:
William Fisher
Diverse Biotech, Inc.
+1 352-552-8985